Loading...
Please wait, while we are loading the content...
Design of the New Closo-Dodecarborate-Containing Gemcitabine Analogue for the Albumin-Based Theranostics Composition.
| Content Provider | Europe PMC |
|---|---|
| Author | Raskolupova, Valeria I. Wang, Meiling Dymova, Maya A. Petrov, Gleb O. Shchudlo, Ivan M. Taskaev, Sergey Yu. Abramova, Tatyana V. Godovikova, Tatyana S. Silnikov, Vladimir N. Popova, Tatyana V. |
| Editor | da Silva, Fernando de Carvalho Ferreira, Vitor Francisco Forezi, Luana Da Silva Magalhães |
| Copyright Year | 2023 |
| Abstract | Combination therapy is becoming an increasingly important treatment strategy because multi-drugs can maximize therapeutic effect and overcome potential mechanisms of drug resistance. A new albumin-based theranostic containing gemcitabine closo-dodecaborate analogue has been developed for combining boron neutron capture therapy (BNCT) and chemotheraphy. An exo-heterocyclic amino group of gemcitabine was used to introduce closo-dodecaborate, and a 5'-hydroxy group was used to tether maleimide moiety through an acid-labile phosphamide linker. The N-trifluoroacylated homocysteine thiolactone was used to attach the gemcitabine analogue to human serum albumin (HSA) bearing Cy5 or Cy7 fluorescent dyes. The half-maximal inhibitory concentration (IC50) of the designed theranostic relative to T98G cells was 0.47 mM with the correlation coefficient R = 0.82. BNCT experiments resulted in a decrease in the viability of T98G cells, and the survival fraction was ≈ 0.4. |
| Journal | Molecules |
| Volume Number | 28 |
| DOI | 10.3390/molecules28062672 |
| PubMed Central reference number | PMC10056911 |
| Issue Number | 6 |
| PubMed reference number | 36985644 |
| e-ISSN | 14203049 |
| Language | English |
| Publisher | Molecular Diversity Preservation International (MDPI) |
| Publisher Date | 2023-03-15 |
| Access Restriction | Open |
| Subject Keyword | boron neutron capture therapy boron delivery agents gemcitabine analogue boronated albumin theranostic conjugate cell viability and proliferation clonogenic assay |
| Content Type | Text |
| Resource Type | Article |
| Subject | Physical and Theoretical Chemistry Medicine Chemistry Drug Discovery Pharmaceutical Science Analytical Chemistry Molecular Medicine Organic Chemistry |